• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Age differences in associations of serum alkaline phosphatase and mortality among peritoneal dialysis patients.

作者信息

Wu Juan, Liu Xin-Hui, Huang Rong, Wu Hai-Shan, Guo Qun-Ying, Yi Chun-Yan, Yu Xue-Qing, Yang Xiao

机构信息

Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China.

Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, Guangdong 510080, China.

出版信息

Chin Med J (Engl). 2019 Jan 20;132(2):232-236. doi: 10.1097/CM9.0000000000000019.

DOI:10.1097/CM9.0000000000000019
PMID:30614855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6365295/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c7/6365295/f7828cfb676d/cm9-132-232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c7/6365295/f7828cfb676d/cm9-132-232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c7/6365295/f7828cfb676d/cm9-132-232-g001.jpg

相似文献

1
Age differences in associations of serum alkaline phosphatase and mortality among peritoneal dialysis patients.腹膜透析患者血清碱性磷酸酶与死亡率之间关联的年龄差异。
Chin Med J (Engl). 2019 Jan 20;132(2):232-236. doi: 10.1097/CM9.0000000000000019.
2
Serum alkaline phosphatase levels correlate with long-term mortality solely in peritoneal dialysis patients with residual renal function.血清碱性磷酸酶水平与残余肾功能的腹膜透析患者的长期死亡率相关。
Ren Fail. 2019 Nov;41(1):718-725. doi: 10.1080/0886022X.2019.1646662.
3
Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.血清钙对血液透析患者甲状旁腺激素和碱性磷酸酶死亡率预测性的效应修饰作用：一项利用2005年至2012年台湾肾脏登记数据系统数据的调查
PLoS One. 2015 Jun 24;10(6):e0129737. doi: 10.1371/journal.pone.0129737. eCollection 2015.
4
Elevated serum alkaline phosphatase and cardiovascular or all-cause mortality risk in dialysis patients: A meta-analysis.血清碱性磷酸酶升高与透析患者心血管或全因死亡风险：一项荟萃分析。
Sci Rep. 2017 Oct 16;7(1):13224. doi: 10.1038/s41598-017-13387-z.
5
Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis.在开始透析的终末期肾病患者中，总碱性磷酸酶和骨特异性碱性磷酸酶随时间推移与骨矿物质密度相关。
J Nephrol. 2017 Apr;30(2):255-262. doi: 10.1007/s40620-016-0292-7. Epub 2016 Mar 18.
6
Serum crosslaps as bone resorption marker in peritoneal dialysis.
Perit Dial Int. 2002 Sep-Oct;22(5):628-30.
7
Phosphorus control in peritoneal dialysis patients.腹膜透析患者的磷控制
Kidney Int Suppl. 2008 Apr(108):S152-8. doi: 10.1038/sj.ki.5002617.
8
Serum Alkaline Phosphatase Levels Predict Infection-Related Mortality and Hospitalization in Peritoneal Dialysis Patients.血清碱性磷酸酶水平可预测腹膜透析患者的感染相关死亡率和住院率。
PLoS One. 2016 Jun 16;11(6):e0157361. doi: 10.1371/journal.pone.0157361. eCollection 2016.
9
Bone alkaline phosphatase and mortality in dialysis patients.骨碱性磷酸酶与透析患者的死亡率。
Clin J Am Soc Nephrol. 2011 Jul;6(7):1752-9. doi: 10.2215/CJN.10091110. Epub 2011 May 19.
10
Relationship between alkaline phosphatase and all-cause mortality in peritoneal dialysis patients.腹膜透析患者碱性磷酸酶与全因死亡率的关系。
Adv Perit Dial. 2013;29:61-3.

引用本文的文献

1
Association between alkaline phosphatase/albumin ratio and the prognosis in patients with chronic kidney disease stages 1-4: results from a C-STRIDE prospective cohort study.碱性磷酸酶/白蛋白比值与1-4期慢性肾脏病患者预后的相关性：C-STRIDE前瞻性队列研究结果
Front Med (Lausanne). 2023 Sep 20;10:1215318. doi: 10.3389/fmed.2023.1215318. eCollection 2023.
2
Associations between liver function parameters and poor clinical outcomes in peritoneal dialysis patients.肝功能参数与腹膜透析患者不良临床结局的关系。
Ther Apher Dial. 2023 Feb;27(1):12-18. doi: 10.1111/1744-9987.13926. Epub 2022 Sep 21.

本文引用的文献

1
Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.碱性磷酸酶：CKD 心血管疾病的新治疗靶点。
Nat Rev Nephrol. 2017 Jul;13(7):429-442. doi: 10.1038/nrneph.2017.60. Epub 2017 May 15.
2
An association between time-varying serum alkaline phosphatase concentrations and mortality rate in patients undergoing peritoneal dialysis: a five-year cohort study.血清碱性磷酸酶浓度随时间变化与腹膜透析患者死亡率之间的关系：一项为期五年的队列研究。
Sci Rep. 2017 Mar 3;7:43314. doi: 10.1038/srep43314.
3
Alkaline phosphatase and mortality in patients on peritoneal dialysis.
腹膜透析患者的碱性磷酸酶与死亡率
Clin J Am Soc Nephrol. 2014 Apr;9(4):771-8. doi: 10.2215/CJN.08280813. Epub 2014 Jan 23.
4
Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.使用碱性磷酸酶和甲状旁腺激素对腹膜透析和血液透析患者进行死亡率预测的比较
Perit Dial Int. 2014 Nov-Dec;34(7):732-48. doi: 10.3747/pdi.2013.00110. Epub 2014 Jan 2.
5
Application of peritoneal dialysis in elderly patients by classifying the age into young-old, old, and oldest-old.通过将年龄分为年轻老人、老年人和高龄老人来探讨腹膜透析在老年患者中的应用。
Contrib Nephrol. 2012;177:48-56. doi: 10.1159/000336935. Epub 2012 May 8.
6
Vascular and valvular calcification in chronic peritoneal dialysis patients.慢性腹膜透析患者的血管和瓣膜钙化
Int J Nephrol. 2011;2011:198045. doi: 10.4061/2011/198045. Epub 2011 Aug 2.
7
Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.血清碱性磷酸酶可预测维持性血液透析患者的死亡率。
J Am Soc Nephrol. 2008 Nov;19(11):2193-203. doi: 10.1681/ASN.2008010014. Epub 2008 Jul 30.
8
Role for alkaline phosphatase as an inducer of vascular calcification in renal failure?碱性磷酸酶在肾衰竭血管钙化中作为诱导剂的作用？
Kidney Int. 2008 May;73(9):989-91. doi: 10.1038/ki.2008.104.
9
Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification.碱性磷酸酶上调与焦磷酸水解：尿毒症血管钙化的潜在机制
Kidney Int. 2008 May;73(9):1024-30. doi: 10.1038/ki.2008.26. Epub 2008 Feb 20.
10
Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification.碱性磷酸酶的新型抑制剂可抑制血管平滑肌细胞钙化。
J Bone Miner Res. 2007 Nov;22(11):1700-10. doi: 10.1359/jbmr.070714.